Korea Investment CORP Takes $23.70 Million Position in Corteva, Inc. $CTVA

Korea Investment CORP purchased a new position in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 279,853 shares of the company’s stock, valued at approximately $23,701,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the period. BlackRock Inc. purchased a new position in shares of Corteva in the 2nd quarter valued at $4,560,180,000. State Street Corp increased its holdings in shares of Corteva by 3.7% in the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares during the period. Franklin Resources Inc. raised its position in shares of Corteva by 4.3% in the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares in the last quarter. Finally, Harris Associates L P lifted its stake in shares of Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Up 0.1%

Shares of NYSE:CTVA opened at $81.84 on Monday. The business’s 50-day moving average is $82.13 and its 200 day moving average is $80.26. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The firm has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a P/E/G ratio of 2.51 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Wall Street Analyst Weigh In

CTVA has been the topic of a number of recent research reports. BMO Capital Markets raised their price objective on Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Rothschild & Co Redburn increased their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Mizuho lifted their price objective on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Finally, BNP Paribas Exane lifted their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.